Glutamate Transporter Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 3697 | 7-Chlorokynurenic acid sodium salt |
| Potent competitive inhibitor of L-glutamate uptake. Sodium salt of 7-Chlorokynurenic acid (Cat. No. 0237) | |
| 0237 | 7-Chlorokynurenic acid |
| Potent competitive inhibitor of L-glutamate uptake | |
| 0111 | Dihydrokainic acid |
| EAAT2 (GLT-1)-selective non-transportable inhibitor of L-glutamate and L-aspartate uptake | |
| 0845 | Evans Blue tetrasodium salt |
| Potent inhibitor of L-glutamate uptake into synaptic vesicles; also non-NMDA iGluR antagonist; P2X antagonist | |
| 0183 | L-(-)-threo-3-Hydroxyaspartic acid |
| Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor | |
| 0298 | L-trans-2,4-PDC |
| Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor | |
| 1223 | DL-TBOA |
| Selective non-transportable inhibitor of EAATs | |
| 2532 | TFB-TBOA |
| Potent and selective EAAT1 and EAAT2 blocker | |
| 3490 | UCPH 101 |
| Selective non-substrate EAAT1 inhibitor | |
| 2652 | WAY 213613 |
| Potent, non-substrate EAAT2 inhibitor |
Huntington's Disease Life Science Poster
Our Huntington's Disease (HD) poster summarizes the pathophysiology and molecular changes that occur in HD.
Request copyDownload PDF